Home/Filings/4/0001608901-20-000002
4//SEC Filing

Fiorino Anthony S. 4

Accession 0001608901-20-000002

CIK 0001208261other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 11:45 AM ET

Size

4.5 KB

Accession

0001608901-20-000002

Insider Transaction Report

Form 4
Period: 2020-02-03
Fiorino Anthony S.
Chief Medical Officer and COO
Transactions
  • Sale

    Common Stock

    2020-02-03$0.00/sh75,000$2630 total

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeother

Related Parties

1
  • filerCIK 0001608901

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 11:45 AM ET
Size
4.5 KB